Medicina
Departamento
Stanford University School of Medicine
Stanford, Estados UnidosPublicaciones en colaboración con investigadores/as de Stanford University School of Medicine (101)
2024
-
Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients
The Lancet Infectious Diseases, Vol. 24, Núm. 1, pp. e59-e68
2023
-
A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: Application to BRCA1 and BRCA2
Human Mutation, Vol. 2023
-
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
Nature Medicine, Vol. 29, Núm. 7, pp. 1867-1876
-
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry
Genome Medicine, Vol. 15, Núm. 1
-
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival
Cancer Medicine, Vol. 12, Núm. 15, pp. 16142-16162
-
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
New England Journal of Medicine, Vol. 389, Núm. 4, pp. 335-347
-
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
Journal of Medical Genetics, Vol. 60, Núm. 12, pp. 1186-1197
-
External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry
International Journal of Cardiology, Vol. 370, pp. 51-57
-
Impact of Post-PCI FFR Stratified by Coronary Artery
JACC: Cardiovascular Interventions, Vol. 16, Núm. 19, pp. 2396-2408
-
Lung abscess and empyema in a heart transplant recipient from Thailand
Transplant Infectious Disease, Vol. 25, Núm. 1
-
Plain language summary of the MajesTEC-1 study of teclistamab for the treatment of people with relapsed or refractory multiple myeloma
Future Oncology, Vol. 19, Núm. 12, pp. 811-818
-
Practical Application of Coronary Physiologic Assessment: Asia-Pacific Expert Consensus Document: Part 1
JACC: Asia, Vol. 3, Núm. 5, pp. 689-706
-
Practical Application of Coronary Physiologic Assessment: Asia-Pacific Expert Consensus Document: Part 2
JACC: Asia, Vol. 3, Núm. 6, pp. 825-842
-
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
Kidney International, Vol. 103, Núm. 2, pp. 391-402
-
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors
Journal of the National Cancer Institute, Vol. 115, Núm. 12, pp. 1605-1615
-
Seven Additional Patients with SOX17 Related Pulmonary Arterial Hypertension and Review of the Literature
Genes, Vol. 14, Núm. 10
-
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer
Nature Communications, Vol. 14, Núm. 1
-
Survival after Invasive or Conservative Management of Stable Coronary Disease
Circulation, Vol. 147, Núm. 1, pp. 8-19
-
WAO consensus on DEfinition of Food Allergy SEverity (DEFASE)
World Allergy Organization Journal, Vol. 16, Núm. 3
-
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
Journal of Pathology: Clinical Research, Vol. 9, Núm. 3, pp. 208-222